Skip to content

MOMCare: Culturally Relevant Treatment Services for Perinatal Depression

For Moms: Culturally Relevant Treatment Services for Perinatal Depression

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01045655
Acronym
MOMCare
Enrollment
168
Registered
2010-01-11
Start date
2010-01-31
Completion date
2014-08-31
Last updated
2016-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Keywords

Depression, Perinatal care, Postpartum period, Pregnancy, Female, Low-income population

Brief summary

The study will evaluate the effectiveness of a culturally relevant, multi-component intervention for antenatal depression. The intervention includes an engagement session, and the woman's choice of brief interpersonal psychotherapy and/or pharmacotherapy in a stepped care treatment for depression model.

Detailed description

The randomized control trial will evaluate the effects of a culturally relevant, multi-component intervention for antenatal depression. MOMCare has the potential to overcome patient, provider, and system-level barriers to care and engage depressed, low-income women in evidence-based treatments to reduce antenatal depressive symptoms, improve maternal psychosocial functioning, and ameliorate postpartum depression. Specific Aim 1: To evaluate the impact of MOMCare on treatment engagement and retention. Specific Aim 2: To evaluate the impact of MOMCare on maternal clinical symptoms and functional outcomes. Specific Aim 3: To conduct an incremental cost-effectiveness analysis for a health care and welfare agency perspective that includes a) tracking the medical costs of health service use in MOMCare and usual care patients; b) monitoring the use of infant preventative health services in both groups; and c) tracking the percentage of women on Medicaid and the percentage working in both groups. The intervention will be assessed through a practical randomized controlled trial in which we have recruited 168 pregnant women with major depression and/or dysthymia who were on Medicaid and/or received Maternal Support Services (MSS) in selected public health centers in Seattle - King County (PHSKC). Patients who were eligible and consented to study enrollment were randomly assigned to either usual care (UC) or MOMCare. Baseline and four follow-up assessments (3 - 18 months post-baseline) are scheduled for study participants in both groups. The MOMCare intervention includes a choice of brief interpersonal psychotherapy or collaborative management of antidepressant medication. Treatment response will be monitored, and the treatment will be adjusted as necessary (adding treatments, increasing dosages).

Interventions

BEHAVIORALMOMCare

8 sessions of brief interpersonal psychotherapy or medication management; maintenance sessions through 12 months postpartum.

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
University of Washington
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 or older * pregnant: 12-32 weeks gestation * able to speak English * telephone access * major depressive disorder or dysthymia * on Medicaid * receiving health care in King County, Washington

Exclusion criteria

* currently in psychotherapy * currently receiving pharmacotherapy from a psychiatrist * high suicide risk * history of bipolar disorder * history of schizophrenia * substance use or dependence in previous 3 months * currently in a relationship with severe interpersonal violence * history of repetitive self-harm behavior

Design outcomes

Primary

MeasureTime frame
SCL-20 depressionbaseline, 3, 6 12, 18 month follow-ups

Secondary

MeasureTime frame
Pregnancy, delivery, birth outcomes6 month follow-up
Child services & outcomes (immunizations, well-child visits)6, 12, 18 month follow-ups
Depression free days & Quality Adjusted Life Years (EuroQol)3, 6, 12, 18 month follow-ups
Quality of depression care process3, 6, 12, 18 month follow-ups
Maternal health services utilization use and estimated costsbaseline, 3, 6 12, 18 month follow-ups
PHQ-9 depressionscreening, baseline, 3, 6, 12, 18 month follow-ups
Edinburgh Postnatal Depression Scalebaseline, 3, 6, 12, 18 month follow-ups
Social Functioning (Work & Social Adjustment, Social & Leisure, Social Support)baseline, 3, 6, 12, 18 month follow-ups
Inventory of Functional Status After Childbirth (IFSAC)6, 12, 18 month follow-ups
Number of depression treatment sessions attended3, 6, 12, 18 month follow-ups

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026